Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01003860 · ClinicalTrials.gov registry record
Postoperative Analgesia After Shoulder Replacement
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 39
- Enrollment target
NCT01003860 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 39 participants.
The verdict
NCT01003860 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
A comparison was made regarding opioid analgesic usage immediately after elective shoulder replacement and for seven days at home between patients randomly given either 0.5% or 0.75% ropivacaine via interscalene block prior to surgery. It is hypothesized that no significant difference will exist between both groups with respect to pain medication used in the hospital and for a 7-day period at home.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01003860
The ClinicalTrials.gov registry entry for NCT01003860 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01003860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01003860 about?
NCT01003860 is a clinical study titled "Postoperative Analgesia After Shoulder Replacement". A comparison was made regarding opioid analgesic usage immediately after elective shoulder replacement and for seven days at home between patients randomly given either 0.5% or 0.75% ropivacaine via interscalene block prior to surgery. It is hypothesized that no significant difference will exist be...
What is the current status of trial NCT01003860?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2006-06. Estimated completion is 2007-04.
Who is sponsoring clinical trial NCT01003860?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.